N post article (today) from stockhouse..
  ID Biomedical                          expects FDA to                          approve trials                          Strep vaccine: Regulator had                          imposed 25-year ban
                           Drew Hasselback                          Financial Post 
                           VANCOUVER - ID Biomedical Corp. said                          yesterday it expects the U.S. Food and                          Drug Administration to approve further                          testing for its vaccine against Group A                          streptococcus, a bacteria responsible for                          everything from sore throats to flesh-eating                          disease. 
                           An FDA official contacted yesterday                          refused comment, saying a U.S. law bars                          the regulator from speaking about the                          status of approvals. 
                           But Dean Linden, an ID spokesman,                          insisted FDA approval is imminent for the                          company to continue its human tests at                          higher dosages of the vaccine. 
                           ID's experimental vaccine is interesting in                          the light of the FDA's 1979 decision to ban                          licensing for Group A strep vaccines for 25                          years. The ban flowed from concerns that                          an earlier experiment for a possible Group                          A strep vaccine triggered rheumatic fever. 
                           While the FDA's licensing ban did not                          prohibit clinical trials for possible Group A                          strep vaccines, pharmaceutical companies                          lost interest in developing them because the                          ban meant that even a successful vaccine                          would never have been allowed on the                          market. 
                           That changed last October when ID                          became the first company in 20 years to                          launch a clinical trial for its proposed                          vaccine. The initial Phase I study, which is                          taking place at the University of Maryland,                          involves administering a test vaccine to 30                          human volunteers. 
                           ID now has the initial results from that                          study. According to Dr. Anthony Holler, a                          former emergency room medical doctor                          who is now president of ID, the results                          suggest that not only is the vaccine safe,                          but also that it is generating antibodies that                          could immunize people from a variety                          Group A strep bug strains. "We know                          we've hit a home run," Dr. Holler said. 
                           Development of ID's experiemental vaccine                          is still at a very early stage. It could be                          another five years before ID finishes                          testing the vaccine in humans, then obtains                          FDA approval for commercialization. The                          licensing ban remains on the books, but                          FDA has said that it is considering                          dropping it. 
                           Group A strep has been linked to a variety                          of illnesses. Some, such as strep throat, can                          be treated with antibiotics. 
                           But others are far more dangerous. Jim                          Henson, creator of the Muppets, died in                          1990 from a pneumonia caused by the bug.                          And Lucien Bouchard, Quebec's Premier,                          lost a leg to "flesh-eating disease", a rare                          strain of Group A strep.  |